QR kód

COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis

ObjectiveTo evaluate the safety of COVID-19 vaccines in patients with multiple sclerosis (MS) by assessing their impact on serum neurofilament light chain (sNfL) levels as a marker of neuroaxonal damage.MethodsSingle-center observational longitudinal study including patients with MS who consecutivel...

Celý popis

Uloženo v:
Hlavní autoři: Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Raquel Sainz-Amo, Lucienne Costa-Frossard, Jaime Masjuan, Luisa María Villar
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2024-08-01
Edice:Frontiers in Immunology
Témata:
SARS-CoV-2 immunization
neuroaxonal damage
sNfL
multiple sclerosis
COVID-19 vaccines
safety
On-line přístup:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1439393/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky